GlassScriptPhysician profile
Sandra N Soliman
NPI 1083321889
$1,672.98
in general payments reported to CMS, 2019-2025
17 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $726 · 2024: $672 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,641 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.71 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $493.18 | 2023-2025 | Optimizer, Optimizer |
| Medtronic, INC. | $230.73 | 2023-2025 | Linq II, Cobalt Dr Mri Surescan, Micra |
| Lexicon Pharmaceuticals, INC. | $137.25 | 2023-2024 | Inpefa |
| Actelion Pharmaceuticals US, INC. | $121.82 | 2023 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.07 | 2024-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $104.98 | 2024-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $87.90 | 2024-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $77.39 | 2023-2024 | Xarelto |
| Biotronik INC. | $65.71 | 2023 | Oscar |
| Amgen INC. | $56.79 | 2025 | Repatha |
| Merck Sharp & Dohme LLC | $45.67 | 2023 | Verquvo |
| Scpharmaceuticals INC. | $33.84 | 2023-2024 | |
| Amryt Pharma Holdings LTD | $27.53 | 2023 | Juxtapid |
| Kiniksa Pharmaceuticals International, Plc | $23.99 | 2024 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $21.37 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16.72 | 2025 | Arexvy |
| Kestra Medical Technology Services, INC. | $16.04 | 2024 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Soliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.